August 17, 2018
On August 16, 2018 Aretha Franklin died from pancreatic neuroendocrine cancer. She was 76.
The Queen of Soul shared her incredible talent with the world, and inspired us all with her spirit and grace.
Her family’s statement: “Franklin’s official cause of death was due to advanced pancreatic cancer of the neuroendocrine type, which was confirmed by Franklin’s oncologist, Dr. Philip Phillips of Karmanos Cancer Institute.”
More than 54,000 people will be diagnosed with pancreatic cancer every year, and more than 44,000 patients will die from the disease. Despite medical advances, there have been no improvements in the mortality rate– more than 91%. Nothing has changed in more than 40 years! We need a new approach.
With no early detection test, more than 85% of patients are diagnosed in an advanced stage. Developing an early detection test for pancreatic cancer would dramatically increase the chances of survival, by catching the disease before it spreads. We continue to advocate for HARPA as the most effective way to develop a detection test and curative treatments for pancreatic cancer.
“Aretha Franklin was a legend who shared her gift with all of us for decades. Her death from pancreatic cancer should be an urgent wake up call to the federal government that the current research model for this disease is not working. There has been no improvement in the mortality rate – 91%! – since Nixon declared the “war on cancer” in 1971. There is still no early detection test or curative treatment. What is taking so long? We need a new approach. HARPA is the most effective way to develop an early detection test for this deadly disease and save thousands of lives. We can do this now.” –Bob Wright, Frmr Vice Chair GE & Chair NBCU; Founder, The Suzanne Wright Foundation; Co-Founder, Autism Speaks
June 25, 2018
A segment from “The Patients Are Waiting: How HARPA Will Change Lives Now”
July 29, 2018
Two years ago today, we lost Suzanne Wright to pancreatic cancer. She was an incredible force, and we channel her energy and passion each and every day.
Nearly 86,000 people have died from pancreatic cancer since Suzanne Wright’s death. We #DemandANewApproach in honor of everyone we have lost to this deadly disease. We need bold action to save lives.
Suzanne lives on in the work she did, the lives she changed, and in the memories of her family and friends. Today, we honor her and those memories.
July 23, 2018
“As an avid reader of obituaries, I’ve been struck by how many people these days are succumbing to pancreatic cancer, a cancer long considered rare.” – Jane Brody, New York Times
Brody writes about the correlation between diabetes, obesity and pancreatic cancer, and how the public might minimize their risk.
Despite accounting for just 3 percent of all cancers, pancreatic cancer is on track to becoming the second most dangerous cancer by 2030. It is one of the deadliest because symptoms rarely develop until the disease is advanced. There are no early detection tests or curative treatments.
July 10, 2018
Dr Maximilian Reichert, lead author of a new study investigating the formation of metastases of pancreatic cancer at the Tum University Hospital Rechts Der Isar, by looking at how cell plasticity affects the spread of pancreatic cancer. The findings were published in the journal Developmental Cell.
“We were able to show that the spread of pancreatic cancer to the liver depends on the plasticity of the cancer cells. If the cells are unable to establish cell-to-cell contacts, they are passively flushed into the lungs by the bloodstream, where they become lodged,” Reichert explains. “This course of the disease is more favorable for patients, because lung tumors are easier to control.”